Coya Therapeutics (COYA) Proxy filing summary

Executive summary

• Annual meeting scheduled for June 25, 2026, to be held virtually at 12:00 p.m. C.T.

• Proxy materials and annual report for the year ended December 31, 2025, are available online for review and voting.

• Shareholders are encouraged to review all proxy materials before voting and can opt for electronic delivery to support environmental initiatives.

Voting matters and shareholder proposals

• Election of two directors: Wilbur Ross and Dieter Weinand, with board recommending a vote FOR both.

• Ratification of Weaver and Tidwell, L.L.P. as independent registered public accounting firm for the year ending December 31, 2026, recommended by the board.

Board of directors and corporate governance

• Board of Directors has provided recommendations for all voting items, supporting all nominees and auditor ratification.